Mark F. Wildhagen

Molecular Cytogenetic Analysis of Prostatic Adenocarcinomas from Screening Studies

Janneke C. Alers, Pieter-Jaap Krijtenburg, André N. Vis et al. · American Journal Of Pathology · 2001 · 73 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Explorative Study of Costs, Effects and Savings of Screening for Female Fragile X Premutation and Full Mutation Carriers in the General Population

Mark F. Wildhagen, Theo A.M. van Os, Johan Polder et al. · Public Health Genomics · 1998 · 71 citations

Medicine, Genetics, Obstetrics +17

Costs, effects, and savings of screening for cystic fibrosis gene carriers.

Mark F. Wildhagen, Henk Hilderink, J. G. Verzijl et al. · Journal of Epidemiology & Community Health · 1998 · 40 citations · Full text

Medicine, Obstetrics, Preventive Medicine +16

Comparison of Single-Entry and Double-Entry Two-Step Couple Screening for Cystic Fibrosis Carriers

Leo P. ten Kate, Mark F. Wildhagen, Henk Hilderink et al. · Human Heredity · 1996 · 16 citations

Medicine, Genetics, Clinical Epidemiology +12

Efficacy of cascade testing for fragile X syndrome

Mark F. Wildhagen, Th. A. M. Van Os, Johan Polder et al. · Journal of Medical Screening · 1999 · 12 citations

Life Sciences, Genetics, Human Genetics +13